Speculations on the future of psychiatric diagnosis

A. John Rush, Hisham M. Ibrahim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V), criterion symptom listings are frequently used in clinical practice as checklists to make diagnoses. However, most DSM-V conditions are, in fact, syndromes, that is, collections of signs and symptoms that commonly occur together in the clinic. This report discusses the value of syndromes in medicine and psychiatry. It is argued that a more precise future enumeration of brain circuits and the pathogenesis of psychiatric conditions will help us better understand and treat psychiatric syndromes, but they are unlikely to eliminate the need to categorize psychiatric conditions. We expect that biomarkers will play an increasingly critical role in psychiatric diagnosis. Beyond a better mechanistic understanding of the DSM-V syndromes, future diagnostic efforts will need to increase the focus on function and address risk factors for nonresponse and relapse. We suggest that new artificial intelligence advances will increase the efficiency and acceptability of psychiatric diagnosis and assist with treatment delivery.

Original languageEnglish (US)
Pages (from-to)481-487
Number of pages7
JournalJournal of Nervous and Mental Disease
Volume206
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Mental Disorders
Diagnostic and Statistical Manual of Mental Disorders
Psychiatry
Advance Directives
Artificial Intelligence
Checklist
Signs and Symptoms
Biomarkers
Medicine
Recurrence
Brain
Therapeutics

Keywords

  • Biomarkers
  • Psychiatric diagnosis
  • Psychiatric syndrome

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Speculations on the future of psychiatric diagnosis. / Rush, A. John; Ibrahim, Hisham M.

In: Journal of Nervous and Mental Disease, Vol. 206, No. 6, 01.06.2018, p. 481-487.

Research output: Contribution to journalArticle

@article{b9830542501746e68686c7760aaeb106,
title = "Speculations on the future of psychiatric diagnosis",
abstract = "The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V), criterion symptom listings are frequently used in clinical practice as checklists to make diagnoses. However, most DSM-V conditions are, in fact, syndromes, that is, collections of signs and symptoms that commonly occur together in the clinic. This report discusses the value of syndromes in medicine and psychiatry. It is argued that a more precise future enumeration of brain circuits and the pathogenesis of psychiatric conditions will help us better understand and treat psychiatric syndromes, but they are unlikely to eliminate the need to categorize psychiatric conditions. We expect that biomarkers will play an increasingly critical role in psychiatric diagnosis. Beyond a better mechanistic understanding of the DSM-V syndromes, future diagnostic efforts will need to increase the focus on function and address risk factors for nonresponse and relapse. We suggest that new artificial intelligence advances will increase the efficiency and acceptability of psychiatric diagnosis and assist with treatment delivery.",
keywords = "Biomarkers, Psychiatric diagnosis, Psychiatric syndrome",
author = "Rush, {A. John} and Ibrahim, {Hisham M.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1097/NMD.0000000000000821",
language = "English (US)",
volume = "206",
pages = "481--487",
journal = "Journal of Nervous and Mental Disease",
issn = "0022-3018",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Speculations on the future of psychiatric diagnosis

AU - Rush, A. John

AU - Ibrahim, Hisham M.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V), criterion symptom listings are frequently used in clinical practice as checklists to make diagnoses. However, most DSM-V conditions are, in fact, syndromes, that is, collections of signs and symptoms that commonly occur together in the clinic. This report discusses the value of syndromes in medicine and psychiatry. It is argued that a more precise future enumeration of brain circuits and the pathogenesis of psychiatric conditions will help us better understand and treat psychiatric syndromes, but they are unlikely to eliminate the need to categorize psychiatric conditions. We expect that biomarkers will play an increasingly critical role in psychiatric diagnosis. Beyond a better mechanistic understanding of the DSM-V syndromes, future diagnostic efforts will need to increase the focus on function and address risk factors for nonresponse and relapse. We suggest that new artificial intelligence advances will increase the efficiency and acceptability of psychiatric diagnosis and assist with treatment delivery.

AB - The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V), criterion symptom listings are frequently used in clinical practice as checklists to make diagnoses. However, most DSM-V conditions are, in fact, syndromes, that is, collections of signs and symptoms that commonly occur together in the clinic. This report discusses the value of syndromes in medicine and psychiatry. It is argued that a more precise future enumeration of brain circuits and the pathogenesis of psychiatric conditions will help us better understand and treat psychiatric syndromes, but they are unlikely to eliminate the need to categorize psychiatric conditions. We expect that biomarkers will play an increasingly critical role in psychiatric diagnosis. Beyond a better mechanistic understanding of the DSM-V syndromes, future diagnostic efforts will need to increase the focus on function and address risk factors for nonresponse and relapse. We suggest that new artificial intelligence advances will increase the efficiency and acceptability of psychiatric diagnosis and assist with treatment delivery.

KW - Biomarkers

KW - Psychiatric diagnosis

KW - Psychiatric syndrome

UR - http://www.scopus.com/inward/record.url?scp=85051826213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051826213&partnerID=8YFLogxK

U2 - 10.1097/NMD.0000000000000821

DO - 10.1097/NMD.0000000000000821

M3 - Article

C2 - 29781887

AN - SCOPUS:85051826213

VL - 206

SP - 481

EP - 487

JO - Journal of Nervous and Mental Disease

JF - Journal of Nervous and Mental Disease

SN - 0022-3018

IS - 6

ER -